Parexel Biotech Collaborates with Synairgen on Pivotal Phase III Trial for Study of Inhaled COVID-19 Treatment
20 oct. 2020 07h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
24 sept. 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C. and ESCHBORN, Germany , Sept. 24, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to...
Parexel Completes Purchase of Roam Analytics’ Natural Language Processing Capability
22 sept. 2020 11h35 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel Announces Solution for EU Clinical Trials Information System Regulation
21 sept. 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from...
Parexel and Pfizer Enter Next Phase of Decade-Long Partnership
27 août 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel’s Deb Tatton Named to 2020 PharmaVOICE 100
03 août 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world...
Parexel Expands Global Regulatory Capabilities with Experts from FDA, EMA, NMPA and Spanish AEMPS
23 juil. 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and TriNetX Partner to Advance Real-world Data Use in Clinical Development
18 juin 2020 08h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., and CAMBRIDGE, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Parexel and TriNetX today announced a strategic effort through which they will securely connect healthcare data to...
Parexel Adds APANDEMIC and Datavant to Lead Ongoing Advancement of #KeepingPatientsFirst Platform
16 juin 2020 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., June 16, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...
Parexel and Society for Clinical Research Sites Host Joint Summit of Site and Patient Advisory Councils Focused on Optimizing Site and Patient Relationships in Clinical Trials
20 mai 2020 15h41 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., May 20, 2020 (GLOBE NEWSWIRE) -- Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health,...